Dysport Approved in UK to Treat Upper Limb Spasticity in CP Children
News
The U.K.’s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved Dysport (abobotulinumtoxin A) for the treatment of upper limb spasticity in children with cerebral palsy. This follows its previous ... Read more